Crystal Arthropathies: Clinical Trials

4 trials for Crystal Arthropathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 31Unknown 1

Follow Crystal Arthropathies: new trials by email Literature Review of Crystal Arthropathies trials Research Report on Crystal Arthropathies

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
Febuxostat 20MG Tablets, Febuxostat 20MG Placebo, AR882 25MG - Primary Gout, Hyperuricemia
Phase 2 / Phase 3UnknownGuangzhou Ruianbo Pharmaceutical Technology Co., Ltd6362024-04-222024-09-19
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg, Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg, Colchicine 0.5 mg - Gout Arthritis
Phase 2UnknownSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1572024-03-302024-08-05
Oral Huzhang Granules for Acute Gouty Arthritis
Huzhang granule, Etoricoxib, Huzhang granule Placebo - Gouty Arthritis
Phase 2UnknownShanghai Yueyang Integrated Medicine Hospital2672020-07-012020-07-08
Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
levotofisopam - Hyperuricemia, Gout
Phase 2UnknownPharmos202012-01-012012-01-27

Narrower conditions

Arthritis, Gouty (2)  ·  Gout (2)  ·  Hyperuricemia (2)

Broader conditions

Arthritis (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Joint Diseases (4)  ·  Metabolic Diseases (4)  ·  Metabolism, Inborn Errors (4)  ·  Musculoskeletal Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (4)  ·  Rheumatic Diseases (4)  ·  Gout (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Colchicine (1)  ·  Drug Contamination (1)  ·  Etoricoxib (1)  ·  Febuxostat (1)  ·  tofisopam (1)

Sponsors

Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd (1)  ·  Pharmos (1)  ·  Shanghai Yueyang Integrated Medicine Hospital (1)  ·  Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (1)

Countries

China (2)  ·  United States (1)

Top investigators

Hejian Zou, MD (1)  ·  Jia Zhou (1)  ·  John S. Sundy, MD, PhD (1)  ·  Qinghong Zhou (1)

Results publications

PMID 35365187